Cardiff Lexington Corporation

Cardiff Lexington Corporation

CDIX
Cardiff Lexington CorporationUS flagOther OTC
4.02
USD
-0.43
- -
27.85MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
270.89
272.58
1,150,251
406,442
37,114.43
3,707,360
150,132.96
13,386.26
5,511.96
2,462.25
2.17
1.66
2.28
Basic EPS, GAAP
-199,687.18
-3,995.04
-773.72
-2,254,492
-912,998.75
-104,420.85
-7,179,906
-193,137.35
902.84
-2,996.75
467.04
-1.12
-0.94
-1.93
Free Cash Flow per Basic Share
-3,725.93
-211.96
-36.33
-216,800
-156,926
-32,513.6
-767,837
-41,218
-1,429.21
-593.13
-357.6
-0.7
-0.41
-0.5
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
8,167.39
276.26
52.96
- -
0.03
0.01
- -
Book Value per Share
-475,102.96
-11,943.27
-8,473.41
-45,436,133
-12,278,326.75
-922,966.67
-61,881,089
-2,851,216.87
-88,009.92
-36,137.96
-14,267.57
-19.12
-11.47
-17.39
Tangible Book Value per Share
-32,973.38
-50.21
-120.94
-2,537,306
-863,682.75
-293,417.63
-22,840,974
-35,018,741.43
-109,968.55
-43,482.22
-17,019.51
-14.65
-1.98
-2.39
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
4
7
5
Sales/Revenue/Turnover
- -
1
1
1
2
2
4
3
10
11
12
8
12
11
Operating Margin (%)
- -
-1,398.56
-281.4
-187.75
-124.34
-90.76
-34.29
-52.25
16.82
36.54
43.83
-2.34
9.65
0.42
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-11
-13
-4
-2
-4
-6
-7
-3
1
-5
3
-3
-6
-8
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
-1,474.81
-283.85
-196
-224.63
-281.35
-193.67
-82.16
6.74
-50.78
25.55
-39.94
-47.74
-75.16
Working Capital
-2
-1
-2
-4
-5
-7
-11
-13
-5
-3
- -
1
-3
-1
LT Debt
- -
- -
- -
- -
- -
1
1
- -
- -
- -
- -
- -
- -
- -
Total Equity
-2
- -
-1
-2
-3
-5
-7
-9
1
-1
7
8
3
6
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
67.89
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
32.44
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
15
19
20
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
51
11
11
Shares Outstanding
7
14
15
Market Capitalization
9
34
19

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
21
23
24
Cash, Cash Equivalents & STI
- -
- -
1
Accounts Receivable, Net
21
22
23
Inventories
- -
- -
- -
Total Current Liabilities
22
26
24
Payables & Accruals
7
7
3
ST Debt
15
19
20
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-61.58%
-200.84%
-59.57%
Free Cash Flow
51.18%
26.33%
7.49%
Net Income, GAAP
-129.16%
-267.29%
66.75%
Sales/Revenue/Turnover
33.52%
42.89%
39.48%
Total Cash Common Dividend
- -
-30.11%
14.17%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2
1
1
3
8
2025
3
3
3
3
12
2026
2
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.34
-0.11
-0.47
- -
-1.12
2025
-0.14
-0.24
-0.21
- -
-0.94
2026
-2.32
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.02
- -
- -
0.03
2025
0.01
- -
- -
- -
0.01
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Alex Hunt Cunningham
Full Time Employees
15
Sector
Financial Services
Industry
Asset Management
Address
401 East Las Olas Boulevard Fort Lauderdale FL United States of America 33301
IPO Date
Dec 22, 2005
Business
Cardiff Lexington Corporation (CDIX), a Nevada-based holding company founded in 1986 and headquartered at 3753 Howard Hughes Parkway, Suite 200, Las Vegas, NV, focuses on acquiring, capitalizing and growing undervalued middle-market niche companies primarily in the healthcare sector; it operates through wholly owned subsidiaries offering specialized medical services and real estate holdings. The company's flagship subsidiary, Nova Ortho and Spine LLC (acquired in 2021), provides a comprehensive range of diagnostic imaging, surgical interventions, primary care evaluations, interventional pain management, and specialty consultations for orthopedic, spine and pain conditions, targeting traumatic injury victims including those with skeletal system disorders involving bones, joints, tendons, muscles, ligaments and nerves; services encompass hip and knee replacements, shoulder reconstructions, fracture care, hand surgery and spinal procedures, delivered across 12 facilities primarily in Florida and Georgia with strategic expansion into Southeast U.S. population centers, serving 250-325 patients monthly through referrals from personal injury attorneys, insurers, physical therapists and chiropractors; revenue derives mainly from bodily injury, general liability and personal injury protection policies. Its real estate segment, Edge View Properties Inc. (acquired in 2014), holds approximately 23 acres in Salmon, Idaho, zoned for medium- and high-density residential development plus agricultural use, with ongoing plans for a joint venture to advance a housing concept project. In recent developments, Cardiff Lexington sold its Platinum Tax Defenders financial services subsidiary in 2023 to streamline operations; expanded Nova Ortho and Spine by opening several new locations in 2024 across Florida and the Southeast, driving a 26% year-over-year revenue increase to $2.9 million in Q1 2025 with operating income up 148% to $544,000 and non-GAAP adjusted EBITDA up 5%; and simplified its capital structure in early 2025 via conversions of long-standing preferred shares to common stock, enhancing support for growth and share liquidity.

Company News

APIChat
  • Cardiff Lexington's Nova Ortho and Spine Announces New Medical Office in Stuart, Florida to Serve the Growing Treasure Coast Community

  • Cardiff Lexington Announces First Quarter 2026 Financial Results

  • Cardiff Lexington to Report First Quarter 2026 Financial Results and Host Conference Call on Tuesday, May 19, 2026

  • Cardiff Lexington Corporation Announces Upgrade to OTCQX Best Market

  • OTC Markets Group Welcomes Cardiff Lexington Corporation to OTCQX

  • Cardiff Lexington Announces Fourth Quarter and Full Year 2025 Financial Results

  • Cardiff Lexington To Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on Monday, March 16, 2026

  • Cardiff Lexington Subsidiary Nova Ortho and Spine Announces New Healthcare Hires to Support Growth

  • Cardiff Lexington Corporation Engages Investment Bank to Lead S-1 Filing and Nasdaq Uplist Strategy

  • Cardiff Lexington Announces 1-for-3 Reverse Stock Split

  • Cardiff Lexington Announces Planned Retirement of Daniel Thompson as Chairman of the Board of Directors

  • Cardiff Lexington Subsidiary Nova Ortho and Spine Performs First Procedures at Doctor's Memorial Hospital in Perry, Florida

  • Cardiff Lexington Enters Advisory Agreement with Greentree Financial Group

  • Cardiff Lexington Announces Third Quarter 2025 Financial Results

  • Cardiff Lexington to Report Third Quarter 2025 Financial Results and Host Conference Call on Friday, November 14, 2025

  • Cardiff Lexington Announces Second Quarter 2025 Financial Results

  • Cardiff Lexington To Report Second Quarter 2025 Financial Results and Host Conference Call on Tuesday, August 26, 2025

  • Cardiff Lexington Postpones Second Quarter 2025 Earnings Press Release and Investor Call

  • Cardiff Lexington Announces Second Quarter 2025 Financial Results

  • Cardiff Lexington Announces Uplisting to OTCQB Venture Market